Dupilumab group:None

2 trials

Sponsors

Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Xiangya Hospital of Central South University

Conditions

Atopic dermatitisatopic dermatitis

Phase 4

Study on biomarkers of targeted therapy for atopic dermatitis

RecruitingChiCTR2300076625

Xiangya Hospital of Central South Universityatopic dermatitis

Start: 2022-01-01Updated: 2023-10-16

Unknown Phase

Molecular Phenotype and Precision Medicine of Atopic Dermatitis in Chinese Population

Active, not recruitingChiCTR2200064667

Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical CollegeAtopic dermatitis

Start: 2022-10-01Updated: 2023-05-15